Corient Private Wealth’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$716K Sell
22,069
-12,067
-35% -$388K ﹤0.01% 1835
2025
Q4
$1.2M Buy
34,136
+18,211
+114% +$645K ﹤0.01% 1790
2025
Q3
$419K Buy
15,925
+2,933
+23% +$87.5K ﹤0.01% 1913
2025
Q2
$344K Sell
12,992
-224
-2% -$5.9K ﹤0.01% 1915
2025
Q1
$319K Buy
13,216
+797
+6% +$25.2K ﹤0.01% 1818
2024
Q4
$500K Sell
12,419
-396
-3% -$22.6K ﹤0.01% 1617
2024
Q3
$811K Buy
12,815
+486
+4% +$28.5K ﹤0.01% 1507
2024
Q2
$654K Sell
12,329
-9,971
-45% -$654K ﹤0.01% 1508
2024
Q1
$1.83M Buy
22,300
+828
+4% +$36.8K ﹤0.01% 1062
2023
Q4
$400K Buy
+21,472
New +$281K ﹤0.01% 1727

Other funds holding VKTX